Fadraciclib TQ0053
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
CYC065 is an orally available, second-generation ATP-competitive inhibitor of CDK2/CDK9 kinases (IC50s: 5/26 nM).
CAS nr:
1070790-89-4
Purity:
98%
Molecular Weight:
397,52
SMILES:
CC[C@@H]([C@@H](C)O)Nc1nc(NCc2c(C)cc(C)nc2)c2ncn(C(C)C)c2n1
Formula:
C21H31N7O
Pathway:
Cell Cycle/Checkpoint
Target:
CDK
